Showing results (51-60 of 990) with videos related to
Sort By:
Pageof 99
Pharmacy World & Science : PWS|July 3, 2004
Do pharmacists' reports of adverse drug reactions reflect patients' concerns?Kees van Grootheest, Eugène P van Puijenbroek, Lolkje T W de Jong-van den BergPharmacy World & Science : PWS|July 3, 2004
An economic evaluation of the costs and benefits of heparin rationalisation in a hospital pharmacyPenny Reeves, Jonathan Cooke, Adam Lloyd, et al.Pharmacy World & Science : PWS|February 3, 2005
Assessing the pharmaceutical care needs of asthmatic patientsF P C A Costa, C Duggan, J W F van MilPharmacy World & Science : PWS|February 3, 2005
Outcome of upper gastro-intestinal bleeding and use of ibuprofen versus paracetamolWilliam J Blot, Thomas Fischer, Gunnar Lauge Nielsen, et al.Pharmacy World & Science : PWS|February 3, 2005
The quality of drugs in private pharmacies in Lao PDR: a repeat study in 1997 and 1999Lamphone Syhakhang, Cecilia Stålsby Lundborg, Björn Lindgren, et al.Pharmacy World & Science : PWS|February 3, 2005
Pharmacoeconomic assessment of oseltamivir in treating influenza--the case of otherwise healthy Danish adolescents and adultsMajbrit Vindt Holm, Marlene Gyldmark, Ebba Holme HansenPharmacy World & Science : PWS|February 5, 2000
Economic evaluation of Viaflex with vial adapter in a unit-dose drug distribution systemA Ortega, A Robles, C Lacasa, et al.Pharmacy World & Science : PWS|June 25, 1999
New therapeutic targets for rheumatoid arthritisH J Dinant, B A DijkmansPharmacy World & Science : PWS|June 25, 1999
Cost-effectiveness analysis of tropisetron vs. chlorpromazine-dexamethasone in the control of acute emesis induced by highly emetogenic chemotherapy in childrenI Tejedor, A Idoate, M Jiménez, et al.Pharmacy World & Science : PWS|July 31, 1999
Academic detailing improves identification and reporting of adverse drug eventsR G Schlienger, T F Lüscher, R A Schoenenberger, et al.Pageof 99